Novelix Pharmaceuticals Ltd. - TRIMURTHI, 536565 corporate action history

Novelix Pharmaceuticals Ltd.

BSE: 536565 | GSM

Download real time

26.61 0.00 (0.00%)

New 52W High today

20,102 BSE Volume

High volume today

BSE 15 Apr, 2025 11:49 AM (IST)

26.5

Market Cap

Below industry Median

-0.2

Beta 1Year

Very Low volatility

Novelix Pharmaceuticals Ltd. Bonus history

Novelix Pharmaceuticals Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for Novelix Pharmaceuticals Ltd.

Novelix Pharmaceuticals Ltd. has split the face value 2 times since Oct. 15, 2009. Novelix Pharmaceuticals Ltd. had last split the face value of its shares from ₹1 to ₹10 in 2010.The share has been quoting on an ex-split basis from Oct. 4, 2010.

Ex-Date	Old FV	New FV	Record Date
04 Oct 2010	1	10	05 Oct 2010
15 Oct 2009	10	1	16 Oct 2009

See all forthcoming Bonus and split

Dividend history for Novelix Pharmaceuticals Ltd.

Novelix Pharmaceuticals Ltd. has declared 4 dividends since Sept. 1, 2009.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
16 Aug 2012	0.30	FINAL	-	Equity Share
22 Sep 2011	0.30	FINAL	-	Equity Share
23 Aug 2010	0.03	FINAL	-	Equity Share
01 Sep 2009	0.30	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Novelix Pharmaceuticals Ltd.

The latest board meeting for Novelix Pharmaceuticals Ltd. took place on 12 Apr 2025, for the purpose of Others

Ex-Date	Purpose	Notes
12 Apr 2025	Others	Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters.
12 Feb 2025	Quarterly Results	-
13 Nov 2024	Quarterly Results & Others	Inter-alia, 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024.
21 Oct 2024	To consider issue of Warrants	(Revised)
02 Sep 2024	Others	Inter alia, to consider 1. Amendment of Main Objects of the Company. 2. Change in name of the Company. 3. Change in the Registered Office of the Company.
08 Aug 2024	Quarterly Results	-
28 May 2024	Audited Results	-
05 Mar 2024	Preferential issue of shares	-
30 Jan 2024	Quarterly Results	-
15 Dec 2023	Quarterly Results	-

See all Board Meetings for Novelix Pharmaceuticals Ltd.

Novelix Pharmaceuticals Ltd. Rights history

Novelix Pharmaceuticals Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Novelix Pharmaceuticals Ltd.

Is Trimurthi Ltd. worth buying?

7 Votes:

Buy 85.71%

Sell 14.29%